and/or
151 News Items found
In the Clinic
Jedd Wolchok and Charlotte Ariyan in the lab
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch
A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.
In the Lab
abstract red and blue lines suggestive of metabolic pathways
Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
In the Lab
A gray blob marked RAS linked to colorful rods marked ICMT
Deciphering How Membrane Enzymes Work, with a Little Help from Beetles
The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.
In the Lab
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
In the Lab
Three-dimensional reconstruction of the blood vessels in a mouse thymus using light-sheet fluorescent microscopy
New Hope for Repairing a Damaged or Aging Immune System
Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.
Q&A
MP1104 binding to the kappa opioid receptor
Building a Safer Opioid: MSK Research Seeks to Develop New Ways to Relieve Pain
Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.
In the News
Gears with 2016 and 2017
Year in Review: The Science and Technology that Shaped Cancer Care in 2017
As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.
In the Lab
Sloan Kettering Institute Director Joan Massagué with laboratory member Karuna Ganesh
When Cancer Spreads: Research Focuses on Better Ways to Treat Metastasis
MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.
In the Lab
A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor
With Help of CRISPR, Scientists Unravel the Cause of a Rare Liver Cancer
A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.
Feature
Former MSK president Paul Marks
The Man behind the Prize: How Paul Marks Shaped Modern Cancer Research
Recent advances in epigenetic and targeted therapies owe a lot to the foresight of former MSK President Paul Marks, who believed in the importance of basic research.